(Q43943343)
Statements
1 reference
A multicenter phase II study of sorafenib monotherapy in clinically selected patients with advanced lung adenocarcinoma after failure of EGFR-TKI therapy (Chinese Thoracic Oncology Group, CTONG 0805). (English)
1 reference
1 reference
Qing Zhou
1 reference
Cai-cun Zhou
1 reference
Gong-yan Chen
1 reference
Ying Cheng
1 reference
Cheng Huang
1 reference
Li Zhang
1 reference
Chong-rui Xu
1 reference
Ai-wu Li
1 reference
Hong-hong Yan
1 reference
Jian Su
1 reference
Xu-chao Zhang
1 reference
Jin-ji Yang
1 reference
5 January 2014
1 reference
1 reference
83
1 reference
3
1 reference
369-373
1 reference
Identifiers
1 reference
1 reference